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Background: To systematically review in- and outpatient costs in patients with coronary artery disease (CAD) and
comorbid mental disorders.
Methods: A comprehensive database search was conducted for studies investigating persons with CAD and
comorbid mental disorders (Medline, EMBASE, PsycINFO, Psyndex, EconLit, IBSS). All studies were included which
allowed a comparison of in- and outpatient health care costs (assessed either monetarily or in terms of health care
utilization) of CAD patients with comorbid mental disorders (mood, anxiety, alcohol, eating, somatoform and personality
disorders) and those without. Random effects meta-analyses were conducted and results reported using forest plots.
Results: The literature search resulted in 7,275 potentially relevant studies, of which 52 met inclusion criteria. Hospital
readmission rates were increased in CAD patients with any mental disorder (pooled standardized mean difference (SMD)
= 0.34 [0.17;0.51]). Results for depression, anxiety and posttraumatic stress disorder pointed in the same direction with
heterogeneous SMDs on a primary study level ranging from −0.44 to 1.26. Length of hospital stay was not increased in
anxiety and any mental disorder, while studies on depression reported heterogeneous SMDs ranging from −0.08 to 0.82.
Most studies reported increased overall and outpatient costs for patients with comorbid mental disorders. Results for
invasive procedures were non-significant respectively inconclusive.
Conclusions: Comorbid mental disorders in CAD patients are associated with an increased healthcare utilization in
terms of higher hospital readmission rates and increased overall and outpatient health care costs. From a health care
point of view, it is requisite to improve the diagnosis and treatment of comorbid mental disorders in patients with CAD
to minimize incremental costs.
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Comorbid mental disorders are common in CAD pa-
tients [1-3]. A significant increase of in- and outpatient
costs in patients with other physical diseases such as dia-
betes, asthma and back pain has been documented [4-6].
However, while CAD has been associated with increased
mortality [7] and diminished quality of life [8,9], data
regarding health care costs in CAD patients are* Correspondence: baumeister@psychologie.uni-freiburg.de
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unless otherwise stated.inconsistent. For example, depression in patients with
CAD was associated with increased readmission rates in
one study (d = 0.63; 95%-CI: 0.61-0.65) [10], whereas an-
other study reported decreased readmission rates for de-
pressed CAD patients compared to CAD patients
without depression (d = −0.44; 95%-CI: −0.81- -0.07)
[11]. Hence, the aim of the present study was to system-
atically review the association between comorbid mental
disorders and in- and outpatient costs in CAD patients.
The following research questions will be addressed:
1) Are in- and outpatient costs increased in CAD
patients with mental disorders compared to CAD
patients without mental disorders?tral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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to specific mental disorder subtypes?
Methods
Data collection for this systematic review was part of a
larger systematic review on quality of life and health care
costs in somatically ill patients with comorbid mental
disorders [4-6,9]. The present review focusses on direct
costs of CAD patients with comorbid mental disorders
compared to CAD patients without mental comorbidity.
The reporting of this study follows the PRISMA (Preferred
Reporting Items for Systematic Reviews and Meta-
Analyses) statement as detailed in the PRISMA checklist
provided as supplementary document.
Inclusion criteria
Studies investigating adult patients (≥18 years) with
CAD (International Classification of Disease Criteria
10th Revision [ICD-10]: I20-I25) in outpatient or in-
patient settings as well as community samples were in-
cluded. Inclusion of primary studies was not further
limited to specific clinical subgroups in order to increase
the generalizability of the results of the review.
Studies were included that allowed the categorization
of mental disorders or psychological burden correspond-
ing to the following diagnostic categories: 1) mental and
behavioral disorders due to use of alcohol (ICD-10: F10;
DSM-IV: 303.xx, 291.xx), 2) mood disorders (ICD-10:
F30-F39; DSM-IV: 292.xx, 296.xx; 300.4, 301.13, 311), 3)
anxiety disorders (ICD-10: F40-F43; DSM-IV: 300.0x,
300.2x, 308.3, 309.81), 4) somatoform disorders (ICD-10:
F45; DSM-IV: 300.7, 300.81), 5) eating disorders (ICD-10:
F50; DSM-IV: 307.1, 307.5x), 6) disorders of adult person-
ality and behavior (ICD-10: F60; DSM-IV: 301.x), or 7) any
mental disorder (i.e. assessment of psychiatric symptoms
in general). For inclusion, primary studies had to allow for
a comparison regarding health care costs between a group
with one of the mentioned mental disorders, and a group
without mental comorbidities.
Primary studies were included if they assessed any direct
health care costs either monetarily or in terms of utilization of
health care resources. Direct inpatient (hospital readmissions,
invasive procedures), outpatient (physician visits, emergency
room visits and rehabilitation) and other health care costs
such as hospital transfer were included.
Search strategy
The database search was conducted in Medline,
EMBASE, PsycINFO, Psyndex, EconLit and IBSS for ar-
ticles published until 24 February 2014 using the search
structure ‘coronary artery disease’ and ‘mental disorders’
and ‘health care costs/health care utilization’. The com-
prehensive search strategy for Medline can be requested
from the first author.In a preliminary sensitive selection process, one
reviewer (AH or MM) screened titles and abstracts of
English- or German-language articles relating to cost
studies in CAD (N = 7,273) (Figure 1). Then, two re-
viewers (two out of HB, AH, MM, NH) independently
selected relevant studies for inclusion by examining the
remaining titles, abstracts or full papers (N = 1,883). In
the case of disagreement, a third reviewer of the author
team was asked to review the article, and disagreements
were solved by consensus discussion. When multiple
articles were published on the same study sample, the
most comprehensive paper was selected as reference art-
icle. Further potentially relevant studies were retrieved
by examining the reference lists of included studies and
through an identification of published articles citing in-
cluded studies (Web of Science Cited Reference Search).
In addition, experts in the area were contacted and
asked about published or unpublished studies that are
relevant to the review.
Data abstraction
Two reviewers (two out of HB, AH, MM, NH) extracted
data from primary studies independently using a data
extraction form. Information about participants (sample
size, sex and age), type of CAD, mental disorder, assess-
ment method of mental disorders (standardized diagnos-
tic interview, self-report questionnaire, medical record
or physician’s diagnosis), cut-off scores used to indicate
mental disorders on self-report questionnaires, means
and standard deviations of mental disorder scores and
descriptive statistics of outcomes were extracted.
Quantitative data analysis
The data analysis was completed using Stata Statistical
Software 9.0 (StataCorp, College Station, Texas, USA)
and Review Manager 5.0 (Nordic Cochrane Centre,
Copenhagen, Denmark). Standardised mean differences
(SMD as Hedges’ g) with 95%-CIs using the pooled
standard deviation of both groups for continuous data
and Odds ratios (OR) (95%-CI) for dichotomous data
were computed.
In studies examining more than two groups represent-
ing different grades of severity of specific mental disor-
ders (e.g. no depression, minor depression, and major
depression), the groups of patients with psychiatric
symptoms were merged and compared to patients with-
out psychiatric symptoms (e.g. no depression vs. minor
and major depression). If no measures of variability were
given in study reports, p-values were used to compute
effect sizes.
Forest plots are reported (Figures 2, 3, 4, 5 and 6) for
all outcomes examined in five or more primary studies.
Chinn’s method for converting an OR to effect size was
used to compute SMDs of continuous outcomes that
Figure 1 Selection process of primary studies.
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cluded in the analysis were studies comparing mentally
comorbid patients to patients without mental disorders
using beta-coefficients derived from regression analyses,
due to their methodological shortcomings when used
as measures of effect [13]. Heterogeneity was tested for
statistical significance by using Q-statistics (chi-square
statistic of heterogeneity test). To examine the extent
of heterogeneity, I2 was computed. According to the
Cochrane Handbook for Systematic Reviews of Inter-
ventions, I2 of 0%-60% can be regarded as not import-
ant to moderate (0–60%), while I2 > 60% indicates
substantial heterogeneity [14]. Random-effects meta-
analyses were conducted for calculating pooled estimates
(SMD/OR with 95%-CI), in case of none-substantial
heterogeneity.
Results
The literature search revealed 7275 potentially relevant
studies, of which 52 (53 articles) met inclusion criteria
(see Table 1) [10,11,15-65].
The majority of studies analyzed depressive disorders
and mood disorders (N = 40) [10,11,15-17,20-26,28,30-34,
36-38,40,41,44-48,50,52,54,55,57,59-65], followed by anxiety
disorders (N = 7) [26,37,47,50,53,63,64] and post-traumaticstress disorder (PTSD) (N = 3) [37,42,43]. Ten studies
investigated any mental disorder [18,19,25,29,35,39,49,
51,56,58]. Comorbid mental disorders were assessed by
database records (N = 12) [10,16,18,23,25,29,39,40,49,
51,53,58], clinical interviews (N = 9) [11,21,24,41,52,54,
60,62,65] and screening questionnaires (N = 35) [15,17,
19,20,22,24,26,28,30-38,42-48,50,54-57,59,61-65]. Health
care costs were assessed by database records (N = 36)
[10,11,15,16,18,20,22,24,29,30,32-34,36,39,40,42-45,47-54,
56-59,61-63,65] and patient self-report (N = 15) [17,19,
21,26,28,31,33,35-38,46,50,60,64]. Two studies did not
describe the assessment of health care costs [41,55].
Inpatient health care
Hospital readmission rates were examined in 29 studies
(Table 1) [10,11,15,19,20,28,32,33,35-38,41,42,44-47,49-51,
55,58-60,62-65] of which 20 reported sufficient data to
compute SMDs ranging from −0.44 to 1.26 (Figure 2)
[10,11,19,20,28,32,33,36,38,41,42,44,47,49,55,58,60,62-65].
Substantial heterogeneity was showed for depression
(I2 = 96%) and anxiety (I2 = 97%), but not for any
mental disorder (I2 = 39%). The meta-analysis indicated
significantly increased hospital readmission rates for
patients with patients with any mental disorder com-
pared to patients without a mental disorder (pooled
Figure 2 Primary studies regarding hospital readmission rates.
Baumeister et al. BioPsychoSocial Medicine  (2015) 9:11 Page 4 of 16SMD = 0.34; 95%-CI [0.17;0.51]). Eleven out of 17 pri-
mary studies reported significantly increased hospital
readmission rates for patients with depression com-
pared to those without (Figure 2). The only study
reporting a contrary finding [11], showed no differences
between major depression and no depression, while pa-
tients with minor depression had the lowest rates of re-
admission, leading to a significantly lower readmission
rate for the combined group of patients with major or
minor depression (SMD= −0.44, Figure 2). This U-shaped
readmission pattern was not reported by any of the other
studies, which mainly did not differentiate between de-
pression severity levels. Both studies on anxiety reported
significantly increased readmission rates for patients with
increased levels of anxiety compared to those without
(SMDs = 0.24 and 1.24, Figure 2). With regard to patients
with comorbid PTSD, Shemesh [42] reported significantlyincreased hospital readmission rates compared to patients
without PTSD (SMD= 0.55, Figure 2).
Twenty-two studies collected data regarding invasive
procedures (Table 1), with eight studies on coronary
catheterization [18,25,26,28,33,40,44,58], nineteen on
CABG [11,21,24-26,28-30,32,33,39,40,43,44,57,59,60,63,64]
and eighteen on PTCA [11,24-26,28-30,32,33,39,40,43,44,
48,57,59,62,63].
Results regarding coronary catheterization rates proved
to be ambiguous with OR ranging from 0.51 to 1.68
[18,25,26,28,33,40,44,58]. Substantial heterogeneity was
showed for any mental disorder (I2 = 99%) and depression
(I2 = 81%). On the primary study level, most studies re-
ported non-significant results, with only three studies
reporting lower ORs and one study reporting a higher OR
for patients with the respective mental disorder compared
to those without (Figure 3).
Figure 3 Primary studies regarding catheterization rates.
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a range of OR from 0.30 to 5.81 (Figure 4) [11,21,
24-26,28-30,32,33,39,40,43,44,59,60,63,64]. Heterogeneity
was substantial for any mental disorder (I2 = 95%), de-
pression (I2 = 84%) and anxiety (I2 = 93%). On the pri-
mary study level, most studies reported non-significant
results, with only three studies reporting lower ORs and
four studies reporting higher ORs for patients with the
respective mental disorder compared to those without
(Figure 3).
The 18 primary studies on PTCA showed a range of
OR from 0.50 to 2.57 (Figure 5) [11,24-30,32,33,39,40,
43,44,48,59,62,63]. Heterogeneity was low to moderate
for any mental disorder (I2 = 39%), low for anxiety (I2 = 0%)
and substantial for depression (I2 = 77%). The meta-
analysis showed a significantly decreased odds for PTCA in
patients with any mental disorder compared to patients
without any mental disorder (OR = 0.71 [0.61;0.84]), while
the estimate was non-significant with regard to anxiety
(Figure 5). Most studies on depression reported non-
significant results, while three studies reported lower ORs
and three studies higher ORs for patients with depression
compared to those without (Figure 5). With regard to pa-
tients with PTSD, the result was non-significant too [43].
Twenty-one studies analyzed length of index hospital
stay [15,16,19,20,22,23,27-29,32-34,39,49,51-54,59,61,63]
(Table 1), of which 15 reported sufficient data to com-
pute SMDs ranging from −0.08 to 0.82 (Figure 6)
[15,16,19,20,22,26-29,32,39,49,54,59,63]. Heterogeneity was
substantial for depression (I2 = 88%) but not for any mental
disorder (I2 = 0%). The meta-analysis showed no significantdifference in length of stay between people with and with-
out any mental disorder. Regarding depression, length of
index hospital stay was significantly increased for patients
with depression compared to patients without depression
in six primary studies, while four primary studies reported
non-significant results. With regard to anxiety, the result
was non-significant in one study [26].
Outpatient health care
Physician visits were investigated in five studies (N = 5)
[17,26,28,32,35]. Frasure-Smith et al. [28] reported sig-
nificantly increased total outpatient visits (SMD = 0.27;
standard error (SE) = 0.07), significantly increased visits
to other medical doctors (SMD = 0.29; SE = 0.07) and
significantly increased visits to a cardiologist (SMD =
0.02; SE = 0.07) for CAD patients with depression com-
pared to CAD patients without depression. Kurdyak
et al. [32] reported significantly increased cardiologist
visits (d = 0.26; SE = 0.05), significantly increased general
internist visits (SMD = 0.15; SE = 0.05) and significantly
increased visits to a family doctor (SMD = 0.19; SE =
0.05) for CAD patients with depression compared to
CAD patients without depression. Grace et al. [26]
found no significant differences in general practitioner
visits for CAD patients with anxiety compared to CAD
patients without anxiety, whereas McGee et al. [17]
found an increased rate of visits to a general physician
for CAD patients with depression compared to CAD pa-
tients without depression (OR = 2.00; 95%-CI: 1.2-3.2).
Studies investigating mental health specialist visits (N = 2)
[28,30] found significantly more visits for CAD patients
Figure 4 Primary studies regarding rates for CABG.
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tients without mental disorders (SMD = 0.16: SE = 0.07
[28]; OR = 5.65: 95%-CI: 2.32-13.78 [30]).
With regard to emergency department visits (N = 4)
[10,26,28,32], Frasure-Smith et al. [28] reported a signifi-
cant effect size of SMD = 0.23 (SE = 0.07) for total emer-
gency department visits and a significant effect size of
SMD = 0.25 (SE = 0.07) for costs of emergency depart-
ment visits in CAD patients with depression compared
to CAD patients without depression. Himelhoch et al.
[10] found significantly increased emergency department
visits (OR = 2.64; 95%-CI: 2.55-2.73) for CAD patients
with depression compared to CAD patients without de-
pression, whereas Grace et al. [26] found no significant
differences in emergency department visits for CAD pa-
tients with anxiety compared to CAD patients without
anxiety. Kurdyak et al. [32] found a significant effect size
of SMD = 0.20 (SE = 0.05) for CAD patients withdepression compared to CAD patients without depres-
sion. Between CAD patients with comorbid mental dis-
orders and CAD patients without mental disorders,
mainly non-significant differences were found (OR
ranged from 0.51 to 0.89) regarding attendance of car-
diac rehabilitation (N = 3) [17,31,49].
Total health care costs
Total health care costs were examined in five studies
[11,28,47,48,56]. Frasure-Smith et al. [28] reported sig-
nificantly increased total health care costs in patients
after a myocardial infarction with comorbid depression
(SMD = 0.14; SE = 0.07). Strik et al. found in two studies
significantly increased health care consumption in pa-
tients after a myocardial infarction with comorbid anxiety
(OR = 2.02; 95%-CI: 1.25-3.25) and depression (OR = 1.61;
95%-CI: 1.00-2.57) [47]; (OR = 1.98; 95%-CI: 1.00-3.93)
[48]. Sullivan et al. compared two groups of patients with
Figure 5 Primary studies regarding rates for PTCA.
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bination of total five-year median costs of $34,670 for
patients with comorbid major depression, $22,183 for pa-
tients with comorbid minor depression and $40,193 for
patients without comorbid depression [11]. Ketterer et al.
[56] found significantly increased hospital costs for CAD
patients with anxiety (normal anxiety level: $8,505; moder-
ately elevated $8,736 and significantly elevated: $12,022)
and phobic anxiety ($8,646; moderately elevated $8,276
and significantly elevated: $13,052) but not for increased
levels of somatization, obsessive-compulsiveness or de-
pression [56].
Discussion
The present meta-analysis is perhaps the first to com-
prehensively summarize the impact of comorbid mental
disorders in CAD patients on a broad range of direct
cost parameters amongst inpatients and outpatients. The
results generally indicated a negative impact of comorbid
mental disorders on hospital readmission rates. Althoughthere were fewer studies reporting outpatient costs such
as physician visits, mental health specialist visits, emer-
gency department visits and attendance of cardiac re-
habilitation programs, meta-analyses indicated increased
costs in CAD patients with comorbid mental disorders.
The finding relating to increased hospital readmission
rates is generally consistent with previous reviews of a
negative impact of depression on cardiovascular events
and mortality in myocardial infarction [66,67]. The
higher readmission rates in CAD patients with comorbid
mental disorders may at least partly reflect the increased
proportion of comorbidities, severity of atherosclerosis,
and perhaps the delay in seeking medical care in patients
with mental disorders [68]. The severity of stenosis in
the left main coronary artery, extent of diffuse coronary
disease unable to be revascularised, proportion of non-
patent grafts, and number of somatic comorbidities have
been shown to be associated with an increased risk of
suffering from comorbid mental disorders [11,66,67].
This raises the question of whether the higher
Figure 6 Primary studies regarding length of index hospital stay.
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cations and somatic comorbidities than by comorbid
mental disorders, a critique described by Nicholson et al.
[69] with respect to left ventricular function. However,
primary studies of the present review also reported a sig-
nificant association between mental disorders and health
care costs after adjusting for somatic comorbidities or
disease severity [10,15,20,25,28,29,31-33,36,38,45,50], in-
dicating that mental comorbidity is an independent pre-
dictor of health care costs in CAD.
Nonetheless, CAD patients with documented severe
mental comorbidity require dedicated mental health
care, potentially leading to higher primary health care
costs (e.g. for medication review, metabolic monitoring,
specialist referral) but also emergency department visits
(e.g. suicidality). Although, based on the finding indicat-
ing significantly higher hospital readmission rates, one
might also expect higher rates of cardiac-related diag-
nostic and revascularization procedures, however, find-
ings were inconsistent. A potential explanation relates to
evidence indicating that persons with mental disorders
are suboptimally treated or referred for diagnostic proce-
dures, less likely to receive optimal coronary revasculari-
zation strategies and are susceptible to patient-physician
communication barriers [70,71]. Another possible explan-
ation would be, that differences in invasive proceduresmay vary between patients samples (e.g. acute MI vs. CAD
sample). However, there were no clear pattern derivable
from comparing the characteristics (Table 1) of those
studies which reported significantly lower invasive proced-
ure rates for people with mental disorders compared to
those which reported significantly higher procedure rates
for this group. Thus, it seems more likely, that invasive
procedure rates do not vary substantially between CAD
patients with and without mental disorders.
Notwithstanding the increased readmission rate among
persons with depression or any comorbid mental disorder,
it was found that length of index hospital stay in CAD pa-
tients with comorbid mental disorders was generally not
increased compared to CAD patients without mental dis-
orders, and only marginally increased in most studies on
depression. Although multiple factors likely influence
length of index stay, marginally increased length of stay
among depressed persons is perhaps a broad marker for
their propensity toward postoperative complications, espe-
cially post-revascularization stroke, renal failure and deep
sternal wound infection [72]. Other potential explanations
may relate to accommodation factors such as the requisite
need for supported care, awaiting accommodation in re-
habilitation facilities, and transfer to rural hospital centres.
These well established factors which one would expect to
be more strongly associated with an increased length of
Table 1 Characteristics of included primary studies
# [Ref] First author
(Country)
Year Study sample Health care costs/Resource utilization Mental disorder (Assessment) n
1 [18] Abrams (USA) 2009 AMI Catheterization Any mental disorder (Database) 21745
2 [16] Ahmed (USA) 2007 CAD Length of stay Depression (Database) 2744
3 [19] Allison (USA) 1995 CAD Readmission costs Any mental disorder (SCL-90R) 381
Length of stay
4 [20] Burg (USA) 2003 CABG Cardiac readmission rate Depression (BDI) 89
Length of stay
5 [51] Cai (USA) 2013 MI Readmission Any mental disorder (Database) 287881
Length of stay
6 [21] Carney (USA) 1988 Patients with suspected CAD CABG rate (at one year postdischarge) Depression (DIS) 52
7 [15] Connerney (USA) 2001 CABG Cardiac readmission rate Depression (BDI) 309
Length of stay
8 [23] Dao (USA) 2010 patients undergone CABG Length of stay Depression (medical records) 63 061
9 [52] Dao, Youssef (USA) 2010 Patients undergone CABG Length of stay Depression (MINI Interview) 358
10 [53] Dao (USA) 2012 Patients undergone CABG Length of stay Anxiety (Database) 17885
11 [24] de Jonge (Netherlands) 2007 AMI PTCA Depression (BDI,CIDI) 1205
CABG
12 [25] Druss (USA) 2000 MI Catheterization rate (during index admission) Mood disorders (Database) 113653
CABG rate (during index admission) Any mental disorder (Database)
PTCA rate (during index admission)
13 [54] Edmondson (USA) 2012 ACS Length of stay Depression (BDI/PHQ-9, DISH) 120
14 [55] Foss-Nieradko (Poland) 2012 Patients undergone CABG Readmission rates Depression (BDI) 170
15 [28] Frasure-Smith (Canada) 2000 MI Readmission rate Depression (BDI) 848
Readmission costs
Catheterization rate (during index admission and one year
postdischarge)
CABG rate (during index admission and one year
postdischarge)
PTCA rate (during index admission and one year
postdischarge)
Length of stay (Days in intensive care, Days on ward, Days on
coronary intensive care, Days on ward for cardiac
readmissions)
Outpatient visits (Total outpatient visits, Other MD visits,











Table 1 Characteristics of included primary studies (Continued)
Total emergency department visits, Cost of emergency
department visits
Total health care costs
16 [26,27] Grace (Canada) 2004 Unstable Angina/ MI Catheterization rate (at six month and one year postdischarge) Anxiety (Anxiety Subscale of the primary Care
evaluation of mental disorders, phobic anxiety
subscale of the middlesex Hospital Questionaire)
913
CABG rate (at six month and one year postdischarge) Depression (BDI)




17 [10] Himelhoch (USA) 2004 CAD Readmission rate Depression (Clinical Classification System) 1238895
Emergency department visits
18 [29] Jones (USA) 2005 MI CABG rate (during index admission and 30 days after
discharge)
Any mental disorder (Database) 3368
PTCA rate (during index admission and 30 days after
discharge)
Length of stay
19 [30] Kaptein (Netherlands) 2006 MI CABG rate (during index admission) Depression (BDI) 475
PTCA rate (during index admission)
Symptoms treated by any healthcare worker
Mental health specialist visits
20 [56] Ketterer (USA) 2010 CAD CAD-related total costs (year before evaluation) Any mental disorder (SCL-90R) 164
21 [31] Kronish (USA) 2006 Unstable Angina/ MI Cardiac rehabilitation attendance Depression (BDI) 492






23 [57] Kurdyak (Canada) 2011 AMI PTCA Depression (BCDRS, short form) 1941
CABG
24 [22] Lane (Great Britain) 2000 MI Length of stay Depression (BDI) 288











Table 1 Characteristics of included primary studies (Continued)
Catheterization rate (within 30 days and one year postdischarge)
CABG rate (within 30 days and one year postdischarge)
PTCA rate (within 30 days and one year postdischarge)
Length of stay
26 [34] Levine (USA) 1996 MI Length of stay Depression (BDI) 210
27 [58] Li (USA) 2013 AMI Readmission rate Any mental disorder (Database) 102783
Cathetherization
28 [35] Maeland (Norway) 1989 MI Readmission rate Any mental disorder (ADI) 280
Physician visits
29 [36] Mallik (USA) 2005 CABG Readmission rate Depression (GDS-S) 936
30 [17] McGee (Ireland) 2006 ACS Physician visits Depression (HADS-D/BDI) 681
Cardiac rehabilitation attendance
31 [59] Myers (Israel) 2012 MI CABG Depression (BDI) 632
PTCA
Length of stay
32 [37] Oxlad (Australia) 2006 CABG Cardiac readmission rate Anxiety (DASS) 119
Depression (DASS)
PTSD (PDS)
33 [38] Parashar (USA) 2006 MI Readmission rate Depression (PHQ) 1873
34 [60] Parker (Australia) 2011 ACS Readmission rate Depression (CIDI) 489
CABG
35 [39] Petersen (USA) 2003 MI CABG rate (during index admission and in 90 days after
discharge)
Any mental disorder (Database) 4340
PTCA rate (during index admission and in 90 days after
discharge)
Length of stay
36 [61] Poole (Great Britain) 2014 Patients undergone CABG Length of stay Depression (BDI) 310




38 [40] Rumsfeld (USA) 2003 Unstable Angina/ MI Catheterization rate (during index admission) Depression (Database) 1957
CABG rate (during index admission)
PTCA rate (during index admission)













Table 1 Characteristics of included primary studies (Continued)
40 [49] Scott (Australia) 2005 ACS Readmission rate Any mental disorder (Database) 2156
Length of stay
Cardiac rehabilitation attendance
41 [42] Shemesh (Israel) 2004 MI Cardiac readmission rate PTSD (IES) 76
42 [43] Shemesh (Israel) 2006 MI CABG rate (6–9 months after MI) PTSD (IES) 65
PTCA rate (6–9 months after MI)
43 [44] Shiotani (Japan) 2002 MI Readmission rate Depression (SDS) 1042
Catheterization rate (during index admission)
CABG rate (during index admission)
PTCA rate (during index admission)
44 [45] Smolderen (USA) 2009 AMI Readmissions Depression (PHQ) 481
45 [46] Stern (USA) 1977 MI Readmission rate Depression (SDS) 63
46 [47] Strik (Netherlands) 2003 MI Readmission rate (invasive procedures) Depression, Anxiety (SCL-90) 318
Increased health care consumption
47 [48] Strik (Netherlands) 2004 MI PTCA rate (during index admission) Depression (SCL-90) 206
Increased health care consumption
48 [11] Sullivan (USA) 2003 CAD Cardiac readmission rate Depression (HAM-D/DIS) 198
CABG rate (after 5 years)
PTCA rate (after 5 years)
Total health care costs
49 [50] Tully (Australia) 2008 patients undergoing Readmissions Depression 226
first CABG Anxiety (DASS)




51 [64] Watkins (USA) 2013 CAD Readmission rate Depression (HADS-D) 934
CABG Anxiety (HADS-A)
52 [65] Zuidersma 2013 MI Readmission rate Depression (BDI, CIDI) 2704
ADI = Anxiety, depression and irritability inventory; BCDRS = Brief Carroll Depression Rating Scale; CIDI = Composite International Diagnostic Interview; DASS = Depression Anxiety Stress Scale; DIS = Diagnostic Interview
Schedule for DSM III-R; GDS-S = Geriatric Depression Scale Short Form; IES = Impact of events scale; HADS-D = Hospital Anxiety and Depression Scale – Depression; HAM-D = Hamilton Rating Scale for Depression;











Baumeister et al. BioPsychoSocial Medicine  (2015) 9:11 Page 13 of 16stay in CAD patients with mental disorder, might be lev-
eled out by the use of Diagnosis Related Groups (DRGs),
which limit the length of stay according to the primary
diagnosis at admission. Indeed, CAD patients with comor-
bid mental disorders might need a longer period of conva-
lescence to recover physically to the same degree as CAD
patients without mental disorders, and potentially have
their mental illness exacerbated during a period of
hospitalization or after the rigors of invasive procedures.
Consequently, this might increase the probability of using
healthcare services after discharge for CAD patients with
comorbid mental disorders and might explain both the
higher readmission rates and the higher outpatient and
overall costs. Another possibility which we were not able
to evaluate is that premorbid and postmorbid onset men-
tal disorder may directly influence resource use differently.
For example, some evidence suggests that postmorbid on-
set depression is associated with significantly higher mor-
bidity than premorbid onset depression [60]. Also,
recently we observed that years since panic disorder onset
was associated with longer length of cardiovascular admis-
sions stay [73].
Primary studies mainly investigated depression. It can-
not be assumed that findings relating to depression and
CAD costs are generalizable across depression subtypes
[74,75]. Moreover, the results of this review cannot be
generalized to other mental disorders, as relationships to
health care costs might differ depending on the mental
disorder under study [5]. For example, worries about
one’s health as a symptom of anxiety disorders can lead
to both an adequate utilization of our health care ser-
vices in case of justified worries and an over-utilization
of health care services in case of unsubstantiated extensive
worries. Similarly, avoidance behavior as a characteristic of
anxiety might be associated with both over- and under-
utilization of health care services depending on the pres-
ence of health issues in need of treatment [5,76]. Future
research should clarify the relationship of comorbid men-
tal disorders other than depression with health care costs
in CAD patients, including more severe mental disorders
such as personality disorders, substance abuse, psychoses,
and bi-polar disorders.
With regards to the methodological aspects of the ori-
ginal investigations each of the studies utilized varying
levels of methodological rigor, and consequently may
have introduced heterogeneity in cost estimates. For ex-
ample, some studies used patient-reported data on
health care utilization, which despite evidence of moder-
ate to high reliability of subjective reports [77,78], may
not be reliable in persons with mental disorders. Previ-
ously we highlighted that depressed patients with som-
atic diseases tend to misclassify their disease status [1]
and certainly, the caveats of self-reported disease status
among persons with anxiety disorders is notably proneto bias [79,80]. Such biases in self-reported health care
utilization data would consequently lead to heterogen-
eity in our comparisons between patients with and with-
out mental disorder. Other methodological limitations of
the original studies relate to the assessment of comorbid
mental disorders predominantly based on screening
questionnaires which would potentially comprise pa-
tients with subthreshold syndromes. Previous studies in-
vestigating depression along a continuum from no
depression, minor to major depression showed a U-
shaped association with cost parameters [36,41] which
may not have been evident in our analyses dichotomiz-
ing patients with various severity thresholds. Other
possible sources of methodological heterogeneity may
include that primary studies stemmed from several dif-
ferent countries with different public health care sys-
tems. It has been shown that costs due to hospital
admissions vary between different countries [66]. Even
within the same country, it is possible that the setting
(inpatient or outpatient) has an impact on prevalence rates
of mental disorders and may thus also impact the associ-
ation with health care costs in CAD patients [18,81].
Some methodological limitations should be taken into
account, when reading the results of this systematic re-
view. First, considering that we restricted the search for
eligible studies in the English and German language the
selection process of primary studies may have been
biased towards studies in only two languages. Publica-
tion bias may have occurred and it remains unclear to
what extent non-significant results were not published
in the first instance or retrieved by our search strategy
(e.g. doctoral theses). Furthermore, from a database
search yielding 7273 articles the preliminary selection
was undertaken by one reviewer only, although our sec-
ondary screening process involved two reviewers. Sec-
ond, the analytical synthesis of the health care cost data
was hampered by methodological and statistical hetero-
geneity of the included primary studies. The primary
studies differed regarding the selection of the sample
(e.g. clinical or population-based samples), the assessment
of comorbid mental disorders (standardized interview,
screening questionnaire, self-report), the comparability of
the groups (adjustment of relevant confounding variables),
and the assessment of cost outcomes (monetarily/resource
utilization). To avoid leveling out varying costs across
studies, we only conducted meta-analyses in case of none-
substantial statistical heterogeneity. Moreover, some stud-
ies did not provide sufficient data to compute effect sizes
and it remains an open question whether including the
results of these studies would have changed the finding of
the present review substantially. Notwithstanding these
limitations, this review constitutes a comprehensive and
representative view on direct costs attributable to comor-
bid CAD and mental disorders.
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In conclusion these data suggest that comorbid mental
disorders in CAD patients are associated with an in-
creased healthcare utilization and costs consistent with
previous meta-analyses on other somatic diseases [4-6].
Together with increased work loss days in CAD patients
with mental disorders [82], the present study highlights
the public health relevance of comorbid mental disor-
ders in CAD patients. Even if increases in health care
costs may be justified in some cases and not always indi-
cative for over-utilization, the present finding point to
the need of optimizing health care for people with CAD
and mental disorders by improving the diagnosis and
treatment of comorbid mental disorders in patients with
CAD [83-85]. Recommendations for clinical practice are
to recognize mental disorders in an early stage of treat-
ment, redistribute the allocation of combined mental
and primary health care services for comorbid CAD and
mental disorder, and to ultimately minimize incremental
costs. Thereby, comprehensive approaches such as
blended collaborative care interventions [86-88] might
help to bridge the gap between medical and psychosocial
interventions and thus improve the effectiveness of
health care in CAD patients. The limited number of
cost-effectiveness studies on treating mental disorders
(only examined for depression) in CAD patients con-
ducted so far indicate that societal costs are at least not
increased by adding an evidence-based psychotherapy,
pharmacotherapy or collaborative care intervention to
standard CAD health care [85,86]. Based on preliminary
results of an ongoing systematic review it further seems
as collaborative care interventions for people with CAD
and depression might not only significantly reduce de-
pressive symptoms, but also major cardiac events [89]. If
this proves to be true, treating depression might help to
lower the increased readmission rate for people with
CAD and depression reported in the present study and
thus reduce health care expenditures in the long term.
Competing interest
The authors declare that they have no competing interests.
Authors’ contribution
HB initiated this study. HB, NH and AH contributed to the design of this
study. HB, AH, NH, MM conducted the literature search and data extraction.
HB, AH and NH were responsible for data analysis. HB and AH wrote the
draft of the manuscript. All authors contributed to the further writing of the
manuscript and read and approved the final manuscript.
Funding
This research project was funded by the Landesstiftung Baden-Württemberg.
The article processing charge was funded by the German Research Founda-
tion (DFG) and the Albert Ludwigs University Freiburg in the funding
programme Open Access Publishing.
PJT is supported by the National Health and Medical Research Council of
Australia (Neil Hamilton Fairley —Clinical Overseas Fellowship #1053578). The
funding body had no role in design or interpretation of the study.Author details
1Department of Rehabilitation Psychology and Psychotherapy, Institute of
Psychology, University of Freiburg, Engelbergerstr 41, D-79085 Freiburg,
Germany. 2Medical Psychology and Medical Sociology, Medical Faculty,
University of Freiburg, Freiburg, Germany. 3Freemasons Foundation Centre
for Men’s Health, Discipline of Medicine, School of Medicine, The University
of Adelaide, Adelaide, Australia.
Received: 2 December 2014 Accepted: 10 April 2015References
1. Baumeister H, Kriston L, Bengel J, Härter M. High agreement of self-report
and physician-diagnosed somatic conditions yields limited bias in examining
mental-physical comorbidity. J Clin Epidemiol. 2010;63:558–65.
2. Härter M, Baumeister H, Reuter K, Jacobi F, Hofler M, Bengel J, et al.
Increased 12-month prevalence rates of mental disorders in patients with
chronic somatic diseases. Psychother Psychosom. 2007;76:354–60.
3. Ormel J, von Korff M, Burger H, Scott K, Demyttenaere K, Huang YQ, et al.
Mental disorders among persons with heart disease - results from World
Mental Health surveys. Gen Hosp Psychiatry. 2007;29:325–34.
4. Baumeister H, Knecht A, Hutter N. Direct and indirect costs in persons with
chronic back pain and comorbid mental disorders—A systematic review.
J Psychosom Res. 2012;73:79–85.
5. Hutter N, Schnurr A, Baumeister H. Healthcare costs in patients with
diabetes mellitus and comorbid mental disorders - a systematic review.
Diabetologia. 2010;53:2470–9.
6. Hutter N, Knecht A, Baumeister H. Health care costs in persons with asthma
and comorbid mental disorders - a systematic review. Gen Hosp Psychiatry.
2011;33:443–53.
7. Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for
mortality in patients with coronary heart disease: A meta-analysis. Psychosom
Med. 2004;66:802–13.
8. Baumeister H, Balke K, Härter M. Psychiatric and somatic comorbidities are
negatively associated with quality of life in physically ill patients. J Clin
Epidemiol. 2005;58:1090–100.
9. Baumeister H, Hutter N, Bengel J, Härter M. Quality of life in medically ill
persons with comorbid mental disorders: A systematic review and
meta-analysis. Psychother Psychosom. 2011;80:275–86.
10. Himelhoch S, Weller WE, Wu AW, Anderson GF, Cooper LA. Chronic medical
illness, depression, and use of acute medical services among Medicare
beneficiaries. Med Care. 2004;42:512–21.
11. Sullivan MD. Depression predicts revascularization procedures for 5 years
after coronary angiography. Psychosom Med. 2003;65:229–36.
12. Chinn S. A simple method for converting an odds ratio to effect size for use
in meta-analysis. Stat Med. 2000;19:3127–31.
13. Greenland S, Schlesselman JJ, Criqui MH. The fallacy of employing
standardized regression coefficients and correlations as measures of effect.
Am J Epidemiol. 1986;123:203–8.
14. Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of
Interventions 4.2.6. Cochrane Libr. Chichester, UK: John Wiley & Sons, Ltd; 2006.
15. Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP. Relation
between depression after coronary artery bypass surgery and 12-month
outcome: a prospective study. Lancet. 2001;358:1766–71.
16. Ahmed A, Lefante CM, Alam N. Depression and nursing home admission
among hospitalized older adults with coronary artery disease: a propensity
score analysis. Am J Geriatr Cardiol. 2007;16:76–83.
17. McGee H, Doyle F, Conroy R, La Harpe de D, Shelley E. Impact of briefly-
assessed depression on secondary prevention outcomes after acute
coronary syndrome: a one-year longitudinal survey. BMC Health Serv Res.
2006;6:9.
18. Abrams TE, Vaughan-Sarrazin M, Rosenthal GE. Psychiatric comorbidity and
mortality after acute myocardial infarction. Circ Cardiovasc Qual Outcomes.
2009;2:213–20.
19. Allison TG, Williams DE, Miller TD, Patten CA, Bailey KR, Squires RW, et al.
Medical and economic costs of psychologic distress in patients with
coronary artery disease. Mayo Clin Proc. 1995;70:734–42.
20. Burg MM, Benedetto MC, Soufer R. Depressive symptoms and mortality two
years after coronary artery bypass graft surgery (CABG) in men. Psychosom
Med. 2003;65:508–10.
Baumeister et al. BioPsychoSocial Medicine  (2015) 9:11 Page 15 of 1621. Carney RM, Rich MW, Freedland KE, Saini J, te Velde A, Simeone C, et al.
Major depressive disorder predicts cardiac events in patients with coronary
artery disease. Psychosom Med. 1988;50:627–33.
22. Lane D, Carroll D, Ring C, Beevers DG, Lip GY. Do depression and anxiety
predict recurrent coronary events 12 months after myocardial infarction?
QJM. 2000;93:739–44.
23. Dao TK, Chu D, Springer J, Hiatt E, Nguyen Q. Depression and geographic
status as predictors for coronary artery bypass surgery outcomes. J Rural
Health. 2010;26:36–43.
24. de Jonge P, Denollet J, van Melle JP, Kuyper A, Honig A, Schene AH, et al.
Associations of type-D personality and depression with somatic health in
myocardial infarction patients. J Psychosom Res. 2007;63:477–82.
25. Druss BG, Bradford DW, Rosenheck RA, Radford MJ, Krumholz HM. Mental
disorders and use of cardiovascular procedures after myocardial infarction.
JAMA. 2000;283:506–11.
26. Grace SL, Abbey SE, Irvine J, Shnek ZM, Stewart DE. Prospective examination
of anxiety persistence and its relationship to cardiac symptoms and
recurrent cardiac events. Psychother Psychosom. 2004;73:344–52.
27. Grace SL, Abbey SE, Kapral MK, Fang J, Nolan RP, Stewart DE. Effect of
depression on five-year mortality after an acute coronary syndrome. Am J
Cardiol. 2005;96:1179–85.
28. Frasure-Smith N, Lesperance F, Gravel G, Masson A, Juneau M, Talajic M,
et al. Depression and health-care costs during the first year following
myocardial infarction. J Psychosom Res. 2000;48:471–8.
29. Jones LE, Carney CP. Mental disorders and revascularization procedures in a
commercially insured sample. Psychosom Med. 2005;67:568–76.
30. Kaptein KI, Jonge de P, van den Brink RHS, Korf J. Course of depressive
symptoms after myocardial infarction and cardiac prognosis: a latent class
analysis. Psychosom Med. 2006;68:662–8.
31. Kronish IM, Rieckmann N, Halm EA, Shimbo D, Vorchheimer D, Haas DC,
et al. Persistent depression affects adherence to secondary prevention
behaviors after acute coronary syndromes. J Gen Intern Med. 2006;21:1178–83.
32. Kurdyak PA, Gnam WH, Goering P, Chong A, Alter DA. The relationship
between depressive symptoms, health service consumption, and prognosis
after acute myocardial infarction: a prospective cohort study. BMC Health
Serv Res. 2008;8:200.
33. Lauzon C, Beck CA, Huynh T, Dion D, Racine N, Carignan S, et al. Depression
and prognosis following hospital admission because of acute myocardial
infarction. CMAJ. 2003;168:547–52.
34. Levine JB, Covino NA, Slack WV, Safran C, Safran DB, Boro JE, et al.
Psychological predictors of subsequent medical care among patients
hospitalized with cardiac disease. J Cardiopulm Rehabil. 1996;16:109–16.
35. Maeland JG, Havik OE. Use of health services after a myocardial infarction.
Scand J Soc Med. 1989;17:93–102.
36. Mallik S, Krumholz HM, Lin ZQ, Kasl SV, Mattera JA, Roumains SA, et al.
Patients with depressive symptoms have lower health status benefits after
coronary artery bypass surgery. Circ Cardiovasc Qual Outcomes. 2005;111:271–7.
37. Oxlad M, Stubberfield J, Stuklis R, Edwards J, Wade TD. Psychological risk
factors for cardiac-related hospital readmission within 6 months of coronary
artery bypass graft surgery. J Psychosom Res. 2006;61:775–81.
38. Parashar S, Rumsfeld JS, Spertus JA, Reid KJ, Wenger NK, Krumholz HM, et al.
Time course of depression and outcome of myocardial infarction. Arch
Intern Med. 2006;166:2035–43.
39. Petersen LA, Normand ST, Druss BG, Rosenheck RA. Process of care and
outcome after acute myocardial infarction for patients with mental illness in
the VA health care system: are there disparities? Health Serv Res. 2003;38:41–63.
40. Rumsfeld JS, Magid DJ, Plomondon ME, Sales AE, Grunwald GK, Every NR,
et al. History of depression, angina, and quality of life after acute coronary
syndromes. Am Heart J. 2003;145:493–9.
41. Schleifer SJ, Macari-Hinson MM, Coyle DA, Slater WR, Kahn M, Gorlin R, et al.
The nature and course of depression following myocardial infarction. Arch
Intern Med. 1989;149:1785–9.
42. Shemesh E, Yehuda R, Milo O, Dinur I, Rudnick A, Vered Z, et al.
Posttraumatic stress, nonadherence, and adverse outcome in survivors of a
myocardial infarction. Psychosom Med. 2004;66:521–6.
43. Shemesh E, Koren-Michowitz M, Yehuda R, Milo-Cotter O, Murdock E, Vered
Z, et al. Symptoms of posttraumatic stress disorder in patients woh have
had a myocardial infarction. Psychosomatics. 2006;47:231–9.
44. Shiotani I, Sato H, Kinjo K, Nakatani D, Mizuno H, Ohnishi Y, et al. Depressive
symptoms predict 12-month prognosis in elderly patients with acute
myocardial infarction. J Cardiovasc Risk. 2002;9:153–60.45. Smolderen KG, Spertus JA, Reid KJ, Buchanan DM, Krumholz HM, Denollet J,
et al. The association of cognitive and somatic depressive symptoms with
depression recognition and outcomes after myocardial infarction. Circ
Cardiovasc Qual Outcomes. 2009;2:328–37.
46. Stern MJ, Pascale L, Ackerman A. Life adjustment postmyocardial infarction:
determining predictive variables. Arch Intern Med. 1977;137:1680–5.
47. Strik JJMH, Denollet J, Lousberg R, Honig A. Comparing symptoms of
depression and anxiety as predictors of cardiac events and increased health
care consumption after myocardial infarction. J Am Coll Cardiol.
2003;42:1801–7.
48. Strik JJMH, Lousberg R, Cheriex EC, Honig A. One year cumulative incidence
of depression following myocardial infarction and impact on cardiac
outcome. J Psychosom Res. 2004;56:59–66.
49. Scott IA, Duke AB, Darwin IC, Harvey KH, Jones MA. Variations in indicated
care of patients with acute coronary syndromes in Queensland hospitals.
Med J Aust. 2005;182:325–30.
50. Tully PJ, Baker RA, Turnbull D, Winefield H. The role of depression and
anxiety symptoms in hospital readmissions after cardiac surgery. J Behav
Med. 2008;31:281–90.
51. Cai X, Li Y, Biondi-Zoccai G. Are AMI Patients with Comorbid Mental Illness
More Likely to be Admitted to Hospitals with Lower Quality of AMI Care?
PLoS One. 2013;8:e60258.
52. Dao TK, Youssef NA, Gopaldas RR, Chu D, Bakaeen F, Wear E, et al.
Autonomic cardiovascular dysregulation as a potential mechanism
underlying depression and coronary artery bypass grafting surgery
outcomes. J Cardiothorac Surg. 2010;5:36.
53. Dao TK, Voelkel E, Presley S, Doss B, Huddleston C, Gopaldas R. Gender as a
Moderator Between Having an Anxiety Disorder Diagnosis and Coronary
Artery Bypass Grafting Surgery (CABG) Outcomes in Rural Patients. J Rural
Health. 2012;28:260–7.
54. Edmondson D, Newman JD, Chang MJ, Wyer P, Davidson KW. Depression is
associated with longer emergency department length of stay in acute
coronary syndrome patients. BMC Emerg Med. 2012;12:14.
55. Foss-Nieradko B, Stepnowska M, Piotrowicz R. Effect of the dynamics of
depression symptoms on outcomes after coronary artery bypass grafting.
Kardiol Pol. 2012;70:591–7.
56. Ketterer MW, Knysz W, Khandelwal A, Keteyian SJ, Farha A, Deveshwar S.
Healthcare Utilization and Emotional Distress in Coronary Artery Disease
Patients. Psychosomatics. 2010;51:297–301.
57. Kurdyak PA, Chong A, Gnam WH, Goering P, Alter DA. Depression and
self-reported functional status: impact on mortality following acute
myocardial infarction. J Eval Clin Pract. 2011;17:444–51.
58. Li Y, Glance LG, Lyness JM, Cram P, Cai X, Mukamel DB. Mental Illness,
Access to Hospitals with Invasive Cardiac Services, and Receipt of Cardiac
Procedures by Medicare Acute Myocardial Infarction Patients. Health Serv
Res. 2013;48:1076–95.
59. Myers V, Gerber Y, Benyamini Y, Goldbourt U, Drory Y. Post-myocardial
infarction depression: Increased hospital admissions and reduced adoption
of secondary prevention measures — A longitudinal study. J Psychosom
Res. 2012;72:5–10.
60. Parker G, Hyett M, Walsh W, Owen C, Brotchie H, Hadzi-Pavlovic D. Specificity
of depression following an acute coronary syndrome to an adverse outcome
extends over five years. Psychiatry Res. 2011;185:347–52.
61. Poole L, Leigh E, Kidd T, Ronaldson A, Jahangiri M, Steptoe A. The
combined association of depression and socioeconomic status with length
of post-operative hospital stay following coronary artery bypass graft
surgery: Data from a prospective cohort study. J Psychosom Res.
2014;76:34–40.
62. Reese RL, Freedland KE, Steinmeyer BC, Rich MW, Rackley JW, Carney RM.
Depression and rehospitalization following acute myocardial infarction. Circ
Cardiovasc Qual Outcomes. 2011;4:626–33.
63. Versteeg H, Hoogwegt MT, Hansen TB, Pedersen SS, Zwisler A, Thygesen LC.
Depression, not anxiety, is independently associated with 5-year hospitalizations
and mortality in patients with ischemic heart disease. J Psychosom Res.
2013;75:518–25.
64. Watkins LL, Koch GG, Sherwood A, Blumenthal JA, Davidson JRT, O’Connor
C, et al. Association of anxiety and depression with all‐cause mortality in
individuals with coronary heart disease. J Am Heart Assoc. 2013;2:e000068.
65. Zuidersma M, Conradi HJ, van Melle JP, Ormel J, de Jonge P. Self-reported
depressive symptoms, diagnosed clinical depression and cardiac morbidity
and mortality after myocardial infarction. Int J Cardiol. 2013;167:2775–80.
Baumeister et al. BioPsychoSocial Medicine  (2015) 9:11 Page 16 of 1666. van Melle JP, de Jonge P, Spijkerman TA, Tijssen JG, Ormel J, van Veldhuisen
DJ, et al. Prognostic association of depression following myocardial
infarction with mortality and cardiovascular events: a meta-analysis.
Psychosom Med. 2004;66:814–22.
67. Frasure-Smith N, Lesperance F. Depression and other psychological risks
following myocardial infarction. Arch Gen Psychiatry. 2003;60:627–36.
68. Tully PJ, Newland RF, Baker RA. Cardiovascular risk profile before coronary
artery bypass graft surgery in relation to depression and anxiety disorders:
an age and sex propensity matched study. Aust Crit Care. 2015;28:24–30.
69. Nicholson A, Kuper H, Hemingway H. Depression as an aetiologic and
prognostic factor in coronary heart disease: a meta-analysis of 6362 events
among 146 538 participants in 54 observational studies. Eur Heart J.
2006;27:2763–74.
70. Li Y, Glance LG, Cai X, Mukamel DB. Are patients with coexisting mental
disorders more likely to receive CABG surgery from low-quality cardiac
surgeons? Med Care. 2007;45:587–93.
71. Tully PJ, Higgins R. Depression screening, assessment and treatment for
patients with coronary heart disease: a review for psychologists. Aust
Psychol. 2014;49:337–44.
72. Tully PJ, Baker RA. Depression, anxiety, and cardiac morbidity outcomes
after coronary artery bypass surgery: a contemporary and practical review.
J Geriatr Cardiol. 2012;9:197–208.
73. Tully PJ. A good time to panic? Premorbid and postmorbid panic disorder
in heart failure affects cardiac and psychiatric admissions. Australas
Psychiatry. in press.
74. Baumeister H, Parker G. Meta-review of depressive subtyping models.
J Affect Disord. 2012;139:126–40.
75. Carney R, Freedland K. Is there a high-risk subtype of depression in patients
with coronary heart disease? Curr Psychiatry Rep. 2012;14:1–7.
76. Tully PJ, Cosh SM, Baune BT. A review of the affects of worry and
generalized anxiety disorder upon cardiovascular health and coronary heart
disease. Psychol Health Med. 2013;18:627–44.
77. Ritter PL, Stewart AL, Kaymaz H, Sobel DS, Block DA, Lorig KR. Self-reports of
health care utilization compared to provider records. J Clin Epidemiol.
2001;54:136–41.
78. Lubeck DP, Hubert HB. Self-report was a viable method for obtaining health
care utilization data in community-dwelling seniors. J Clin Epidemiol.
2005;58:286–90.
79. Tully PJ, Baune BT. Comorbid anxiety disorders alter the association
between cardiovascular diseases and depression: the German National
Health Interview and Examination Survey. Soc Psychiatry Psychiatr
Epidemiol. 2014;49:683–91.
80. Goodwin RD, Davidson KW, Keyes K. Mental disorders and cardiovascular
disease among adults in the United States. J Psychiatr Res. 2009;43:239–46.
81. Tully PJ, Cosh S, Baumeister H. The anxious heart in whose mind? A
systematic review and meta-regression of factors associated with anxiety
disorder diagnosis, treatment and morbidity risk in coronary heart disease.
J Psychosom Res. 2014;77:439–48.
82. Haschke A, Hutter N, Baumeister H. Indirect costs in patients with coronary
artery disease and mental disorders: A systematic review and meta-analysis.
IJOMEH. 2012;25:319–29.
83. Baumeister H. Inappropriate prescriptions of antidepressant drugs in
patients with subthreshold to mild depression: time for the evidence to
become practice. J Affect Disord. 2012;139:240–3.
84. Baumeister H. The importance of screening for depression in general
practice. Acta Psychiatr Scand. 2011;124:75.
85. Baumeister H, Hutter N, Bengel J. Psychological and pharmacological
interventions for depression in patients with coronary artery disease.
Cochrane Database Syst Rev. 2011:CD008012.
86. Baumeister H, Hutter N. Collaborative care for depression in medically ill
patients. Curr Opin Psychiatry. 2012;25:405–14.
87. Davidson KW, Rieckmann N, Clemow L, Schwartz JE, Shimbo D, Medina V,
et al. Enhanced depression care for patients with acute coronary syndrome
and persistent depressive symptoms: coronary psychosocial evaluation
studies randomized controlled trial. Arch Intern Med. 2010;170:600–8.
88. Rollman B, Belnap B, LeMenager M, Mazumdar S, Houck P, Counihan P,
et al. Telephone-delivered collaborative care for treating post-CABG
depression: a randomized controlled trial. JAMA. 2009;302:2095–103.
89. Tully PJ, Baumeister H. Collaborative care for the treatment of comorbid
depression and coronary heart disease: a systematic review and meta-
analysis protocol. Syst Rev. 2014;3:127.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
